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Abstract
The Tec cytoplasmic tyrosine kinase is a member of a
family of src-Iike proteins that are thought to play
important roles in hematopoiesis. Here we describe the
temporal and spatial expression of the Tec gene during
embryogenesis and in the aduft. Our data demonstrate
that embryonic Tec expression is restricted to distinct
hematopoietic cells as well as structures and cell types
that share a common feature of containing fluid in an
enclosed cavity, e.g., endothelial cells. In addition, Tec
is expressed in melanocytes late in gestation. The
observed developmental expression pattern of Tee
suggests a role for this gene in several aspects of
hematopoiesis and/or blood vessel development as
well as in late stages of melanogenesis.
Introduction
The Tec (Tyrosine kinase expressed in hepatocarcinoma)
gene encodes a src-like cytoplasmic tyrosine kinase (1) and
constitutes, together with Btk, ltk, Txk, and Drosophila
Drsrc28C, a unique subfamily of Src-Iike proteins (reviewed
in Refs. 2 and 3). Members of the Tee subfamily share several
features, including SH2 and SH3 domains, the presence of a
pleckstrin homology domain in the amino-terminus (reviewed
in Refs. 2 and 3), and the absence of both a putative regu-
latory tyrosine residue in the carboxyl-terminus and the ami-
no-terminal myristylation site that facilitates the translocation
and activation of Src kinases (reviewed in Ref. 4). In addition,
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members of the Tec kinase family possess a unique proline-
rich region of homology, termed the Tec homology region
(reviewed in Aefs. 2 and 3).
Several independent lines of evidence suggest that mom-
bers of the Tec family play a role in hematopoiesis: (a) Tec,
Btk, Itk, and Txk are expressed in hematopoietic cell lines
and tissues (1, 5-9) and have structural motifs consistent
with the role of mediators of cytokine and growth factor
receptor signaling pathways in hematopoietic cells (2, 3); (b)
the introduction of loss-of-function mutations in mouse Btk
or Itk leads to defects in B-cell and in T-cell development,
respectively (10-13). In addition, germ-line mutations in hu-
man BTK are associated with agammaglobulinemia, due to
defective B-cell signaling (14, 15); (c) Tec kinase activity is
induced by lL-3 (i6),￿ erythropoietin (16), IL-6 (17), granulo-
cyte colony-stimulating factor (18), thrombopoietin (19), and
Steel factor (20), cytokines and growth factors that regulate
the proliferation of various hematopoietic cell lineages; and
(a) Tec associates with the Kit RTK (20), a receptor that is
essential for the normal development of early hematopoietic
progenitors as well as cells of the erythroid and mast cell
lineages (reviewed in Ref. 21).
Northern analysis of cultured cell lines indicate that Tec is
expressed in hematopoietic cells (5) as well as melanocytes
(22). In adult mouse tissues, Tec expression has been ob-
served in liver, gut, kidney, heart, ovary, testis, bone marrow,
thymus, and spleen (1, 5, 23, 24).
In this report, we have analyzed the embryonic pattern of
Tec expression in the developing mouse embryo. We show
that Tec is expressed in hematopoietic tissues as well as in
structures that contain fluid in an enclosed cavity, e.g. , en-
dothelial cells surrounding blood vessels, ependymal cells
lining the central canal of the neural tube, the gut epithelium,
and the developing urogenital system. In addition, we dem-
onstrate Tec expression in megakaryocytic cells in the fetal
liver and adult bone marrow. These data support a possible
role for Tee in embryonic and adult aspects of megakaryo-
cytopoiesis as well as angiogenesis and/or vasculogenesis
and the development of other epithelial structures. In addi-
tion, our data support a role for Tec in late, but not early,
aspects of melanocyte development.
Results
Tee Expression at Early Stages of Gestation. We ana-
lyzed the developmental profile of Tee expression by RNA in
situ hybridization on sections prepared from mouse embryos
5 The abbreviations used are: IL interleukin; RTK, receptor tyrosine ki-
nase; CNS, central nervous system; DRG, dorsal root ganglia; rs, reces-
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at various embryonic stages. We first observed Tec expres-
sion at embryonic day 7, in which Tee transcripts were re-
stricted to blood islands within the extraembryonic meso-
dorm and to the endothelial lining of the sinusoids of the
maternal decidua (Fig. 1A). At day 9, strong expression of
Tec was observed in the labyrinth trophoblast layer and the
maternal layer of the placenta; in contrast, Tec expression
was completely absent from the spongiotrophoblast layer
located between labyrinthine trophoblast and maternal lay-
ers (Fig. 1B). Strong expression of Tee was also observed in
the amnion, in the developing heart, in cells surrounding the
CNS, in the urogenital ridge, and in single cells in the blood
(Fig. 1, B, C, and D), whereas modest expression was found
in presumed endothelial cells lining the major blood vessels
(Fig. 1, B, c, and D). The identity of the Tec-positive cells
surrounding the CNS was not established at this stage, but
from results obtained from later embryonic stages, these
cells are likely not to be migrating neural crest cells, but
rather the developing leptomeninges, a vascular structure
that envelopes the CNS.
Tee Expression at Late Somite Stages. At day 10.S
(data not shown) and day 11.5, Tee was expressed in the
developing leptomeninges (Fig. 2, A, B, c, and D) and in the
endothelial lining of blood vessels connecting the leptomen-
inges with either the dorsal aorta or the neuroectoderm of the
neural tube (Fig. 2, c and D). In addition to the apparent
blood vessel-specific expression, we observed strong and
punctate Tec expression in the fetal liver (Fig. 2, A and B), the
main site of hematopoiesis at this stage of embryogenesis.
Tec was also expressed in the epithelial parts of the gut, the
urogenital sinus, the urogenital ridge, and the mesenchyme
located ventrally to the neural tube at the hind limb level (Fig.
2, A and B). This latter site includes the aorta-gonads-me-
sonephros region, which has recently been shown to be the
first location of definitive hematopoiesis in the embryo (25,
26).
Tee Expression during Organogenesis. Between em-
bryonic days 12.5 and 14.5, the expression pattern of Tec
broadened to include other cell lineages and tissues. At both
day 12.5 and day 14.5, we observed Tec expression in the
skin (Fig. 3D; Fig. 4 A, D, and E), Ieptomeninges (Fig. 3, A, B,
and D; Fig. 4, A, B, and D), choroid plexus (Fig. 4A), in the
lining of blood vessels in the CNS (Fig. 3, B, c, and D; Fig. 4,
B and ￿), in the lining of blood vessels surrounding the dorsal
root ganglia (Fig. 3D; Fig. 4, A and 0), in the heart (Fig. 3A;
Fig. 4A), and in a punctate manner identical to that described
for day 11.5 in the liver (Fig. 3A; Fig. 4, A, E, and F). Inter-
estingly, high levels of Tec expression in the liver were re-
stricted to large cells resembling developing megakaryo-
cytes (Fig. 4F), whereas blood vessels in the liver seemed not
to contain Tec mANA (data not shown). At day 14.5, but not
before, we also observed low levels of Tee expression
throughout the liver (Fig. 4, A and E), indicating the onset of
Tee expression in hepatocytes. The expression in the uro-
genital system continued with Tec expression in the kidneys
(Fig. 4A) and, at high levels, in the mesenchyme of the genital
tubercle (Fig. 4A). In addition, Tec continued to be expressed
in the epithelial lining of the gut (Fig. 3A; Fig. 4A). Weak Tec
expression was observed in the lungs and the olfactory
epithelium from day 14.5 (Fig. 4A).
Tec expression in the placenta was very similar to the
pattern observed at day 9: strong expression in the labyrin-
thine trophoblast layer, almost no expression in the spon-
giotrophoblast layer, and moderate expression in the mater-
nal layer (Fig. 3E).
The dynamic pattern of Tec expression was particularly
evident in developing neural structures: at day 12.5, Tec
expression was restricted to the most dorsal ependymal cells
lining the central canal of the neural tube (Fig. 3D), but at day
14.5, this expression had expanded ventrally to include all
ependymal cells lining the central canal (Fig. 4D).
Tee Expression at Late Gestation. At day 18 of embry-
ogenesis, Tec continued to be expressed in the leptomen-
inges, the blood vessels surrounding the DRG, in the tubules
in the kidney, and in lung, liver, and olfactory epithelium as
well as in the epithelial lining of the intestine and the gall
bladder (Fig. 5, A-E). The density of fetal liver cells express-
ing high levels of Tec was decreased compared to the fetal
liver at midgestation (compare Fig. SA and Fig. 4A). In addi-
tion, we observed expression in the tongue and in the thy-
mus, whereas expression in the lining of the blood vessels of
the CNS, in the heart, and the mesenchyme of the genital
tubercle decreased (Fig. SA). In the skin, expression was
markedly reduced and observed mainly in presumed mela-
nocytes in the hair follicles (Fig. 5, B and C).
Tec Expression in Adult Tissues. We confirmed by
Northern analysis previous studies (1 , 5, 23) showing Tec
expression in adult liver, heart, kidney, and gut (Fig. 6A). In
addition, Tec was expressed in bone marrow-derived mast
cells (Fig. 6A).
We also analyzed Tec expression in adult bone marrow by
ANA in situ hybridization. Tec was expressed in a punctate
manner reminiscent of the expression pattern observed in
fetal liver (Fig. 6B). Under higher power, this punctate pattern
of Tee expression seemed to be restricted to cells with a
megakaryocyte-like appearance (Fig. 6C).
Discussion
In this paper, we have used both RNA in situ hybridization
and Northern analysis to study the embryonic and adult
expression pattern of the Tec tyrosine kinase gene. Using
these approaches, we have shown that Tec is expressed in
blood islands at day 7, in single cells in the bloodstream at
day 9, and day 1 1.5, in megakaryocytic cells in the fetal liver
from day 11.5 to day 18, in the thymus at late gestation, and
in megakaryocytic cells in adult bone marrow as well as bone
marrow-derived mast cells. These data suggest a role for this
tyrosine kinase in myeloid and lymphoid development. Inter-
estingly, liver cells expressing high levels of Tec were first
observed at around day 10.5, when hematopoietic activity in
this organ commences. The density of megakaryocytic fetal
liver cells expressing high levels of Tec was greatest during
midgestation and declined at late gestation, consistent with
the decline of hematopoietic activity in the fetal liver in late
gestation. Because Tec encodes a cytoplasmic tyrosine ki-
nase (1), it might function downstream of hematopoietic re-C. . . ￿:
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Fig. 1. Analysis of embryonic
Tec expression by RNA in situ
hybridization. A, at day 7 of ges-
tation, Tec expression was ob-
served in the endothelial lining of
the sinusoids of the maternal de-
cidua (arrowhead) as well as the
blood islands of the yolk sac (ar-
row). No expression was ob-
served in the ectoplacental cone
(ec) or in the embryo proper (em).
B, at day 9 of gestation, Tec ex-
pression was observed in the
placenta in the labyrinthine tro-
phoblast layer (It) and in the ma-
ternal layer (m), but not in the
spongiotrophoblast layer (st).
Tec was also expressed in the
amnion (a), in cells surrounding
the neural tube (n) and develop-
ing brain (b), in the urogenital
ridges (g), in the heart (h), and in
endothelial cells lining the major
blood vessels as well as single
cells in the blood (arrowhead).
Close-up dark-field (C) and
bright-field (D) images of the
blood vessel are marked with an
arrowhead in B. The endothelial
cell layer positive for Tec is
marked with arrowheads,
whereas Tec-positive cells in the
blood stream are marked by an
arrow. Scale bar in D, represents
40 ￿im for A, 200 j.tm for B, and
50 pm for C and D.
Fig. 2. Tec mRNA expression
at day 11.5. Dark-field (A) and
bright-field (B) images of a trans-
verse section through a day 11.5
embryo. The forelimb region is
seen in the upperpart of the pic-
ture, the hind limb region is seen
in the lower half. Tec expression
can be seen in the leptomenin-
ges (Im), the urogenital ridges
(ur), in the liver (Ii), in the gut ep-
ithelium (g), and in the urogenital
sinus (us) as well as in the mes-
enchyme harboring the aorta-
gonads-mesonephros region.
Bright-field (C) and dark-field (D)
images of the neural tube of a
different embryo. Expression of
Tec is seen in the leptomeninges
(Im) surrounding the neural tube
(nt) and in blood vessels sprout-
ing from the leptomeninges into
the neuroectoderm (arrowhead)
as well as in the lining of the left
dorsal aorta (arrow). Scale bar
represents 500 ￿tm for A and B
and 150 ￿im for C and 0.Iii￿
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Fig. 3. Tec mRNA expression at day 12.5. A, sagittal section showing Tec expression in the leptomeninges (Im), the heart (h), the liver (Ii), and the gut
epithelium (g). B, close-up of the brain of a different embryo showing Tec expression in the leptomeninges (Im) and in the lining of blood vessels in the brain
(arrowhead). C, higher magnification of one small blood vessel in the brain (arrowhead) demonstrating silver grains overlaying cells that surround a RBC.
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Fig. 5. Tec mRNA expression at
day 18. A, sagittal section show-
ing Tec expression in the lepto-
meninges (Im), olfactory epithe-
hum (oe), tongue (to), thymus (t),
lung (1), kidney (k), the epithelium
of the gut (g), the lining of the gall
bladder (yb), and in the blood
vessels surrounding the DRG
(drg). In addition, the low-level
expression throughout the liver
(Ii) with interspersed cells ex-
pressing high levels of Tec per-
sisted. The density of fetal liver
cells expressing high levels of
Tec decreased compared to ear-
her stages of embryogenesis.
Tec expression in the heart (h)
was barely detectable. Bright-
field (B) and dark-field (C) images
of the skin demonstrating Tec ex-
pression in the hair follicles (ar-
rows). The strong signal at the
surface of the epidermis repre-
sents a surface artifact that is ob-
served with all probes in embryos
older than day 15.5 for RNA in
situ hybridization. Bright-field (0)
and dark-field (F) images of the
kidney showing Tec expression
in the epithelium of the renal tu-
bules (arrows). Scale bar repre-
sents 3 mm in A, 400 ￿tm in B and
C, and 200 j.tmin D and E.
ceptors as an integral part of their signaling cascade. Indeed,
it has been shown that Tec interacts with the Kit RTK and is
activated after Steel factor stimulation (20). In addition, Tec is
activated by signaling through various cytokine receptors,
including the lL-3, IL-6, and erythropoietin receptors (16, 17).
Interestingly, Tec also becomes rapidly activated by the c-
Mpl cytokine receptor after stimulation with thrombopoietin
(19). The thrombopoietin/c-Mpl signaling pathway supports
the growth and maturation of megakaryocytic cells (27, 28).
Thus, our data showing Tec expression in megakaryocytic
cells throughout fetal liver hematopoiesis would support a
model in which Tec plays an important role in the thrombo-
poietin/c-Mpl signaling pathway during megakaryocyte de-
velopment. Although no mutations in the Tec locus are avail-
able to date, targeted germ-line mutations in two other
members of the Tec gene family, Btk and Itk, affect B-cell
and T-cell development, respectively (10-13). In addition,
germ-line mutations in the human BTK gene lead to agam-
maglobulinemia (14, 15), demonstrating the importance of
other members of the Tec family in hematopoiesis.
We also observed Tec expression in several other devel-
opmental systems. Most strikingly, Tec was expressed in
endothelial cells surrounding blood vessels from day 9. Up to
midgestation, the expression in the blood vessels of the
CNS, blood vessels surrounding the DRG as well as the
leptomeninges, was fairly strong, whereas other blood yes-
sels displayed lower levels of Tec expression. In addition,
Tec expression in the skin at midgestation also most likely
reflects expression in blood vessels. This is supported by the
analysis of midgestational homozygous Vnd￿￿￿ embryos,
which lack melanoblasts and mast cells in the skin (29) but
nevertheless display a normal expression pattern of Tec
(data not shown). Whereas Tec expression in the leptomen-
inges and around the DRG remained strong throughout the
second half of gestation, expression levels dropped signifi-
cantly in blood vessels of the CNS after day 14.5. Tec was
0, Tec expression in a transverse section of the neural tube (nt). Punctate expression is seen in the neuroectoderm; furthermore, expression is seen in the
leptomeninges (Im), the blood vessels surrounding the DRG (d), and in the skin (s). In addition, most ofthe dorsal cells lining the central canal (c) also express
Tec (arrow). E, in the placenta, Tec continues to be expressed in the labyrinthine trophoblast layer (It) and in the maternal layer (ml), whereas expression
is absent in the spongiotrophoblast layer (st). Scale bar represents 800 jxm in A, 100 pm in B, 20 ￿m in C, 150 ￿tm in D, and 1 mm in E.
Fig. 4. Tec mRNA expression at day 14.5. A, sagittal section showing Tec expression in the leptomeninges (Im), choroid plexus (cp), blood vessels
surrounding the drg (drg), in the heart (h), lung (I), kidney (k), skin (s), genital tubercle (gt), in some parts of the olfactory epitheliurn (oe), in the gut epithelium
(g), and at low levels throughout the liver (Ii). In addition, we observed a punctate pattern of cells expressing high levels of Tec in the liver. B, higher
magnification of the brain showing expression in the leptomeninges (Im) and in blood vessels of the brain. C, higher magnification of one blood vessel of
the brain, showing Tec expression in cells encapsulating several RBCs. D, transverse section through the neural tube. Tec expression is seen in the
leptomeninges (Im), the skin (s), blood vessels surrounding the DRG (arrowheads), and in all cells lining the central canal (arrow). E, Tec expression in the
skin (s), the epithelium of the gut (arrowhead), and, in a punctate manner, in the liver (Ii). F, higher magnification oftwo Tec-positive cells in the liver (arrows).
These cells seemed to have a larger, megakaryocyte-like morphology. The silver grains were in a different focal plain and are not visible in this image. Scale
bar represents 2 mm in A, 100 im in B, 30 pin in C, 500 ￿m in 0, 300 Mm in E, and 20 ￿im in F.￿:. ￿￿:-:￿
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Fig. 6. Tec expression in the
adult. A, Northern analysis of
adult tissues showing moderate
Tec expression in liver (Ii) and
kidney (k) and weak Tec expres-
sion in gut (g), heart (h), and mast
cells (mc). Please note that the
mast cell signal was derived from
a Phosphor Imager exposure and
therefore seems stronger than it
would be on film. B, analysis of
Tec expression in adult bone
marrow by RNA in situ hybridiza-
tion. The punctate expression
pattern was reminiscent of the
pattern observed in fetal liver. C,
higher magnification of two
Tec-expressing cells in bone
marrow (arrows; The silver
grains were in a different focal
plain and are only partially visi-
ble in this image). These cells
displayed a megakaryocyte-like
appearance. Tec expression in
bone marrow was mainly ob-
served in cells with this appear-
ance. Scale bar represents 200
￿m in B and 20 ￿m in C.
also highly expressed in the heart at day 9 and decreased
late in gestation.
We demonstrated Tec expression in the placenta at mid-
gestation. High levels of expression were observed in the
labyrinthine trophoblast layer, and moderate levels were ob-
served in the maternal layers, whereas the spongiotropho-
blast layer did not express Tec. The labyrinthine trophoblast
and maternal layers contain blood vessels, whereas the
spongiotrophoblast layer is devoid of blood vessels. Thus,
the pattern of Tec expression might reflect the differential
distribution of blood vessels in the placenta.
Blood vessel development can be divided into vasculo-
genesis (formation of new blood vessels from mesodermal
progenitor cells, e.g. , formation of dorsal aorta, blood is-
lands, endocardium of the heart, and cardinal and vitelline
veins) and angiogenesis (sprouting of new blood vessels
from preexisting vessels, e.g. , formation of intersomitic yes-
sels and vessels in the brain and kidney (reviewed in Ref. 30).
Recently, the Flk-1 , Tek/Tie-2, and Tie RTKs have been
shown to be essential for distinct steps of vasculogenesis
and angiogenesis. A functional Flk-1 receptor is essential for
the earliest steps in the development of both the endothelial
and hematopoietic cell lineages (31 , 32). The Tek/Tie-2 and
Tie receptors are important for the maintenance and reorga-
nization of the embryonic vasculature (33-35). Interestingly,
the embryonic expression pattern of Tec described in this
study is remarkably similar to the embryonic expression pat-
terns of F/k- 1, Tek/Tie-2, and Tie (36). Thus, part of the
biological function of Tec might be as an intracellular relay
station for signaling events downstream of the FIk-1 , Tek/
Tie-2, or Tie RTKs in endothelial and functionally related cell
types.
In addition to endothelial cells, Tec was also expressed in
several cell types thought to play a functionally similar role in
enclosing a fluid-filled space in the embryo. For example, it
has been suggested that ependymal cells lining the central
canal of the CNS are involved in osmoregulation of the cer-
ebrospinal fluid (37). Tec is expressed in the most dorsal
aspect of the lining of the central canal at day 12.5, whereas
Tec-expressing cells surround the central canal by day 14.5.
This dynamic pattern of Tec expression might reflect a pos-
sible dorsal-to-ventral development of the ependymal cells.
Tec was also expressed in the developing urogenital sys-
tem. High levels of expression were observed as early as day
9 in the urogenital ridges. Expression in the urogenital sys-
tem continues at late somite stages with expression in the
urogenital ridges, the urogenital sinus, and mesenchyme and
is found during organogenesis in the mesenchyme of theCell Growth & Differentiation 1255
genital tubercle and at late gestational stages in the epithelial
lining of the gall bladder and the urethra. We also observed
high levels of Tec expression in the tubules of the developing
kidney. This is in agreement with a possible role for Tee in
structures that contain fluid in an enclosed cavity.
Tec was strongly expressed in the epithelial lining of the
gut from day 10.5 on, which again represents a structure that
encloses a fluid-filled space. This expression seemed to
become even more intense at late stages of development.
Expression in the gut epithelium was observed at day 10.S,
before blood vessel development is apparent in this tissue,
as well as in a uniform fashion in all cells of the epithelium.
Therefore, Tec expression seems not to be restricted to
mucosal blood vessels but rather is expressed in the muco-
sal cells themselves. This observation is consistent with a
previous report demonstrating Tec expression in adult intes-
tinal epithelium (23).
At midgestation, we observed strong Tec expression in the
amnion surrounding the embryo. This membrane shares sev-
eral features with the endothelial lining of blood vessels,
including an epithelial-like morphology and the requirement
to contain fluid within an enclosed cavity, and has previously
been shown to express several marker molecules for endo-
thelial cells, including Tek and F/k-i (36).
Interestingly, Tec was also expressed in hair follicles late in
gestation, whereas expression in other parts of the skin was
no longer detectable. Because we have previously demon-
strated Tec expression in adult melanocytes (22), we believe
that the Tec expression in embryonic hair follicles is re-
stricted to this cell type. This conclusion is of interest be-
cause there is a decrease in Tec expression in melanocytes
isolated from homozygous rs mice (22), a coat color mutation
that has been mapped genetically to the vicinity of the W
locus (38). Therefore, Tec is a candidate gene for the rs locus.
The coat color defects in rs/rs animals are restricted to a
small area of depigmentation in the most ventral area of the
trunk and an occasional small white head spot (38). Whereas
the data provided in this report demonstrating Tec expres-
sion in hair follicles late in gestation are consistent with a role
for Tec in late stages of melanoblast development, the ab-
sence of detectable levels of Tee expression in melanoblasts
at day 11.5 is not consistent with a role for Tec in early events
of melanoblast migration.
We have previously reported the molecular and develop-
mental alterations associated with the ￿sV￿c￿ mutation (29).
This regulatory W mutation is associated with a 2.8-Mb in-
version of mouse chromosome 5, with the proximal break-
point located close to the Tec gene, whereas the distal
breakpoint maps to a 160-kb genomic fragment immediately
upstream of the Kit coding sequence. This inversion results
in the juxtaposition of Tec and Kit. Although the V./￿d inver-
sion dysregulates the normal temporal and spatial expres-
sion pattern of Kit, we did not detect any qualitative alter-
ations in Tec expression in W￿’iW￿” mutant embryos or
quantitative alterations in W￿”/Vv’￿” adult tissues (data not
shown). These results suggest that the iiV’￿’ inversion does
not affect regulatory cis-elements important for Tec expres-
sion.
Additional insights into the role of the Tec tyrosine kinase
in hematopoiesis, vasculogenesis/angiogenesis, and devel-
opment of epithelial structures as well as coat color devel-
opment will be obtained from the phenotypic analysis of
mutant mice harboring targeted mutations in the Tec gene.
Materials and Methods
Northern Blot Analysis. Total RNA was extracted as described previ-
ously (39). Briefly, mast cells and mouse tissues were homogenized in 3M
UCI and 6M urea on ice for 1 mm. The homogenate was left on ice in a cold
room overnight. After centnfugation at 10,000 rpm at 4#{176}C for 30 mm, the
pellet was resuspended in UCI and urea and pelleted again. The RNA
pellet was air-dried and resuspended in 10 m￿ Tns-HCI (pH 7.5), 0.5%
SDS, and 5 mM EDTA. Subsequently, the RNA was extracted once with
phenol (pH 4.3)/chlorophorm/isoamylalcohol (25:24:1) and once with
chlorophorm/isoamylalcohol (24:1). The RNA was precipitated by adding
an equal volume of 5M ammonium acetate and 3 volumes of ethanol. The
ANA was resuspended In 200 ￿d of H20 and 0.5% SOS. Total RNA(20 ￿g)
was electrophoresed on a formaldehyde/i % agarose gel and transferred
to a nylon membrane (GeneScreenPlus; New England Nuclear). Full-
length Tec (PCR-generated) and glyceraldehyde-3-phosphate dehydro-
genase cDNAs were 32P-Iabeled using the Pharmacia oligolabeling kit.
Hybridization and washes were performed according to the manufactur-
er’s recommendations (GeneScreenPlus; New England Nuclear).
RNA In Situ HybrIdization. RNA in situ hybridization was performed
essentially as described previously(40). Briefly, tissues and embryos were
cryostat-sectioned at 10 pm, mounted on glass slides treated with 2%
3-aminopropyltnethoxysilane (Sigma), and refixed in 4% paraformalde-
hyde. After prehybndization, sections were hybridized at 55#{176}C with ￿S-
labeled UTP single-stranded RNA antisense and sense probes tran-
scnbed from the full-length Tec cDNA. After posthybridization washes and
dehydration, the slides were dipped into NTB-2 emulsion (Kodak), ex-
posed at 4#{176}C for 4-6 days, developed, and stained with toluidine blue.
Hybridization with the Too sense probe did not result in a detectable
signal.
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